These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 8680047)

  • 1. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
    Fruman DA; Klee CB; Bierer BE; Burakoff SJ
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3686-90. PubMed ID: 1373887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcineurin by a novel FK-506-binding protein.
    Sewell TJ; Lam E; Martin MM; Leszyk J; Weidner J; Calaycay J; Griffin P; Williams H; Hung S; Cryan J
    J Biol Chem; 1994 Aug; 269(33):21094-102. PubMed ID: 7520438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive drugs: the first 50 years and a glance forward.
    Allison AC
    Immunopharmacology; 2000 May; 47(2-3):63-83. PubMed ID: 10878284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
    Baughman G; Wiederrecht GJ; Campbell NF; Martin MM; Bourgeois S
    Mol Cell Biol; 1995 Aug; 15(8):4395-402. PubMed ID: 7542743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
    Yashima Y; Ohgane T
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.
    Liu J; Farmer JD; Lane WS; Friedman J; Weissman I; Schreiber SL
    Cell; 1991 Aug; 66(4):807-15. PubMed ID: 1715244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
    J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.
    Zenke G; Strittmatter U; Fuchs S; Quesniaux VF; Brinkmann V; Schuler W; Zurini M; Enz A; Billich A; Sanglier JJ; Fehr T
    J Immunol; 2001 Jun; 166(12):7165-71. PubMed ID: 11390463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes.
    Clipstone NA; Fiorentino DF; Crabtree GR
    J Biol Chem; 1994 Oct; 269(42):26431-7. PubMed ID: 7523407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
    Dutz JP; Fruman DA; Burakoff SJ; Bierer BE
    J Immunol; 1993 Apr; 150(7):2591-8. PubMed ID: 7681074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.